SCHEMBL5126458

SCHEMBL5126458

CCOC1Oc2c(c(=O)oc3ccc4ccccc4c23)C1c1c(O)c2c(ccc3ccccc32)oc1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 6/20 0.40
GAA P10253 5/20 0.40
GLA P06280 2/20 0.40
ABCG2 Q9UNQ0 3/20 0.38
HPGD P15428 3/20 0.37
MEN1 O00255 3/20 0.37
MAPT P10636 3/20 0.37
KMT2A Q03164 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HSD17B10 Q99714 2/20 0.36
USP2 O75604 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36
NQO1 P15559 1/20 0.36
PSMD14 O00487 1/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5120108 0.84 MEN1 (0.42) ALDH1A1KDM4EGAAGLAABCG2
SCHEMBL5114210 0.81 ALDH1A1 (0.47) ALDH1A1KDM4EGAAHPGDMEN1
SCHEMBL5341622 0.81 ABCG2 (0.42) ALDH1A1KDM4EGAAGLAABCG2
SCHEMBL5119698 0.75 PRNP (0.40) ALDH1A1KDM4EGAAGLAHPGD
SCHEMBL5111977 0.74 NQO1 (0.48) ALDH1A1KDM4EHPGDMEN1MAPT
SCHEMBL5118680 0.74 ESR1 (0.32) NQO1
SCHEMBL5115168 0.74 NQO1 (0.47) ALDH1A1KDM4ENPSR1NQO1POLB
SCHEMBL5125494 0.74 NQO1 (0.47) ALDH1A1MEN1MAPTKMT2ANQO1
SCHEMBL5114980 0.73 NQO1 (0.52) ALDH1A1KDM4EGAAGLAHPGD
SCHEMBL5110816 0.72 ESR2 (0.34) ALDH1A1NQO1POLBMAOBADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action CYP11B2, CYP11B1, LTC4S ALDH1A1 486/4885KDM4E 3765/4885GAA 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.